Thromboprophylaxis with rivaroxaban or enoxaparin did not differ for major bleeding in knee arthroplasty.

The article focuses on efficacy of anticoagulants thromboprophylaxis with rivaroxaban or enoxaparin in preventing bleeding in knee anthroplasty. Hip and knee arthroplasty are associated with a high risk for venous thromboembolism and the use of anticoagulants like warfarin with thromboprophylaxis poses the need for anticoagulant monitoring and subcutaneous administration. It states that neither rivaroxaban nor enoxaparin group differ for major bleeding in knee anthroplasty.